BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//IAS-USA//NONSGML PDA Calendar Version 1.0//EN
CALSCALE:GREGORIAN
BEGIN:VEVENT
UID:187ecbefb83ec8b592df26a441119802
ORGANIZER:registration@iasusa.org
DTSTAMP:20261026T192514Z
LOCATION:
SUMMARY:Nothing Without Us: Civil Society Solutions to the COVID-19 Pandemic
DESCRIPTION:[vc_section][vc_row][vc_column][vc_empty_space][/vc_column][/vc_row][vc_row disable_element="yes" u_row_style="0" u_row_paralax="0" u_row_scheme="0"][vc_column width="1/3"][/vc_column][vc_column width="1/3"][vc_btn title="REGISTER" color="primary" size="lg" i_icon_fontawesome="fas fa-arrow-circle-right" add_icon="true" link="url:https%3A%2F%2Fzoom.us%2Fwebinar%2Fregister%2FWN_0DoAM5ZbRUaDNh-Opbe0sw"][/vc_column][vc_column width="1/3"][/vc_column][/vc_row][/vc_section][vc_row][vc_column][vc_column_text]\n\nOverview\n\nAssessment of Needs\nThe COVID-19 pandemic has created an unprecedented disruption in life as we know it\, affecting not only the public health of communities worldwide but our economic and social wellbeing.\n\nSimilar to some 40 years ago\, the global HIV community of advocates and activists are leading the charge in the grassroots community response against this devastating new pandemic. Our accumulated experience and skills will be the key to finding solutions and providing support to those who are the most overlooked and affected among us.\n\nThe COVID Advocates Advisory Board is a group of civil society organizations and global health advocates committed to bringing communities together and\, by gleaning insight from HIV activism\, setting the path toward resolving the inequities that COVID-19 has exacerbated.\n\nThis session brings together the experience of fierce  HIV and COVID-19 advocates from grassroots organizations around the globe with shared and vital goals of learning from one another\, defining best practices\, valuing the role of communities\, and demanding accountability in the fight for equity in the global COVID-19 response. We invite you to join us for a robust\, interactive discussion on these topics.\nLearning Objectives\nOn completion of this webinar\, learners will be able to:\n\n 	Identify strategies and initiatives being done globally by community advocates and members to address the COVID-19 pandemic\n 	Describe the interactions and parallels in HIV and COVID-19 advocacy\n\nRegistration\nWho Should Attend\nThis webinar is designed for clinical decision makers and community members who are actively involved in HIV and COVID-19 care\, research\, and advocacy.\n\nThis activity is also relevant for nursing professionals\, physician assistants\, pharmacists\, and other health care professionals.\n\nIndividual registration is required\, even if you are viewing as a group\, in order to receive CME credit or a certificate of participation.\n\nRegistration closes on Tuesday\, June 22\, 2021\, 6:00 AM (PT).\n\nCertificates will be available after the completion of the evaluation and claim form.\n\nFor more information or questions\, please contact the registration department at registration@iasusa.org or 415-544-9400.\nConflicts of Interest\nIn the interest of maintaining the independence of its continuing medical education (CME) activities\, the International Antiviral Society–USA (IAS–USA) requires all persons with control of educational content (eg\, faculty\, Scientific Leadership Board\, Governance Board\, and program planner) to disclose any financial relationships with ineligible companies (previously defined as “commercial interests”) that they have had within the past 24 months. Any real or apparent conflicts of interest of those parties are resolved and mitigated prior to the CME activity being delivered. Individuals who refuse to disclose financial interests may not participate in IAS–USA CME activities.  \n\nThe Accreditation Council for Continuing Medical Education (ACCME) defines ineligible companies as "those whose primary business is producing\, marketing\, selling\, re-selling\, or distributing healthcare products used by or on patients.” \n\nIAS–USA will identify and resolve ahead of time any possible conflicts of interest that may influence CME activities with regard to exposition or conclusion. Information about financial relationships with ineligible companies for the presenter and planners/reviewers is below and in the slides prior to the presentation of educational content.\n\n\n\n\n\nContinuing Education Credits\n\nCME Credits\nUnfortunately\, due to administrative oversight\, the live activity is not available for CME. However\, the on-demand activity is now eligible for CME.\n\n\n\n\nGrant Support\n\n\nThis activity is part of the IAS–USA national educational effort that is funded\, in part\, by charitable contributions from commercial companies. Per IAS–USA policy\, any effort that uses commercial grants must receive grants from several companies with competing products. Funds are pooled and distributed to activities at the sole discretion of the IAS–USA. Grantors have no input into any activity\, including its content\, development\, or selection of topics or speakers. Generous support for this activity has been received from the following contributors.\n\nPLATINUM SUPPORTERS\n\nGilead Sciences\, Inc.\nMerck &amp\; Co.\, Inc.\nViiV Healthcare\n\nSILVER SUPPORTER\n\nJanssen Therapeutics\n\nBRONZE SUPPORTER\n\nTheratechnologies Inc.\nFrequently Asked Questions\nView our list of FAQs about attending a webinar.\n\nFurther Questions?\nPlease contact the registration department at registration@iasusa.org or 415-544-9400.\n\n\n\n[/vc_column_text][/vc_column][/vc_row]
STATUS:CONFIRMED
CATEGORIES:Webinars
URL;VALUE=URI:https://www.iasusa.org/events/webinar-2021-civil-society-solutions-to-covid-19/
DTSTART:20210622T140000Z
DTEND:20210622T151500Z
END:VEVENT
END:VCALENDAR